{"id":"W2589251389","doi":"10.1200/jco.2014.32.3_suppl.353","title":"Cost-effectiveness of <i>nab</i>-paclitaxel plus gemcitabine versus erlotinib plus gemcitabine in metastatic pancreatic cancer.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Gemcitabine; Medicine; Pancreatic cancer; Erlotinib; Internal medicine; Nab-paclitaxel; Taxane; Oncology; Clinical trial; Adverse effect; Deoxycytidine; Paclitaxel; Cancer; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003579712,0.0009280664,0.001390785,0.001115598,0.0002261198,0.001400286,0.0007555309,0.001198958,0.00298975],"category_scores_gemma":[0.006550439,0.0004000457,0.004262653,0.0008711971,0.0004914077,0.001160318,0.0008339853,0.001518627,0.0001606935],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003775898,"about_ca_system_score_gemma":0.001599316,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004301518,"about_ca_topic_score_gemma":0.003858487,"domain_scores_codex":[0.9970189,0.00216505,0.0001722934,0.0001411159,0.0002258538,0.0002767245],"domain_scores_gemma":[0.9976847,0.001121764,0.0006082613,0.00005207016,0.00008435812,0.0004489274],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7080484,0.006814005,0.0209879,0.003256978,0.01439502,0.0003634683,0.000107525,0.05814781,0.001904879,0.001804725,0.002404222,0.181765],"study_design_scores_gemma":[0.2572763,0.3448039,0.1652018,0.002578893,0.05259903,0.00194422,0.0007781854,0.1535703,0.005031056,0.005791701,0.01009708,0.0003274636],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9683173,0.02273363,0.0007912178,0.001661197,0.0002746823,0.0009405626,0.0009622528,0.00004426279,0.004274942],"genre_scores_gemma":[0.9968821,0.001757134,0.0004110321,0.0002312117,0.00005875666,0.0001825188,0.000276759,0.00000426844,0.0001963577],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004301518,"threshold_uncertainty_score":0.02739614,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2854647360034754,"score_gpt":0.5416867612353754,"score_spread":0.2562220252319,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}